These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30077176)

  • 1. Improvement of carbonyl reductase activity for the bioproduction of tert-butyl (3R,5S)-6-chloro-3,5-dihydroxyhexanoate.
    Liu ZQ; Yin HH; Zhang XJ; Zhou R; Wang YM; Zheng YG
    Bioorg Chem; 2018 Oct; 80():733-740. PubMed ID: 30077176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Directed Evolution of Carbonyl Reductase from Rhodosporidium toruloides and Its Application in Stereoselective Synthesis of tert-Butyl (3R,5S)-6-Chloro-3,5-dihydroxyhexanoate.
    Liu ZQ; Wu L; Zhang XJ; Xue YP; Zheng YG
    J Agric Food Chem; 2017 May; 65(18):3721-3729. PubMed ID: 28425285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of tert-butyl (3R,5S)-6-chloro-3,5-dihydroxyhexanoate using carbonyl reductase coupled with glucose dehydrogenase with high space-time yield.
    Zhang XJ; Zheng L; Wu D; Zhou R; Liu ZQ; Zheng YG
    Biotechnol Prog; 2020 Jan; 36(1):e2900. PubMed ID: 31486281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale synthesis of tert-butyl (3R,5S)-6-chloro-3,5-dihydroxyhexanoate by a stereoselective carbonyl reductase with high substrate concentration and product yield.
    Liu ZQ; Hu ZL; Zhang XJ; Tang XL; Cheng F; Xue YP; Wang YJ; Wu L; Yao DK; Zhou YT; Zheng YG
    Biotechnol Prog; 2017 May; 33(3):612-620. PubMed ID: 28268261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of tert-butyl (3R,5S)-6-chloro-3,5-dihydroxyhexanoate by carbonyl reductase from Rhodosporidium toruloides in mono and biphasic media.
    Liu ZQ; Wu L; Zheng L; Wang WZ; Zhang XJ; Jin LQ; Zheng YG
    Bioresour Technol; 2018 Feb; 249():161-167. PubMed ID: 29040850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric synthesis of tert-butyl (3R,5S)-6-chloro-3,5-dihydroxyhexanoate using a self-sufficient biocatalyst based on carbonyl reductase and cofactor co-immobilization.
    Zhang XJ; Wang WZ; Zhou R; Liu ZQ; Zheng YG
    Bioprocess Biosyst Eng; 2020 Jan; 43(1):21-31. PubMed ID: 31542820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric synthesis of tert-butyl (3R, 5S) 6-chloro-dihydroxyhexanoate with Lactobacillus kefir.
    Amidjojo M; Franco-Lara E; Nowak A; Link H; Weuster-Botz D
    Appl Microbiol Biotechnol; 2005 Nov; 69(1):9-15. PubMed ID: 15723213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-evolution of activity and thermostability of an aldo-keto reductase KmAKR for asymmetric synthesis of statin precursor dichiral diols.
    Qiu S; Cheng F; Jin LJ; Chen Y; Li SF; Wang YJ; Zheng YG
    Bioorg Chem; 2020 Oct; 103():104228. PubMed ID: 32891863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly efficient enzymatic synthesis of tert-butyl (S)-6-chloro-5-hydroxy-3-oxohexanoate with a mutant alcohol dehydrogenase of Lactobacillus kefir.
    He XJ; Chen SY; Wu JP; Yang LR; Xu G
    Appl Microbiol Biotechnol; 2015 Nov; 99(21):8963-75. PubMed ID: 26004803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced diastereoselective synthesis of t-Butyl 6-cyano-(3R,5R)-dihydroxyhexanoate by using aldo-keto reductase and glucose dehydrogenase co-producing engineered Escherichia coli.
    Wang YJ; Shen W; Luo X; Liu ZQ; Zheng YG
    Biotechnol Prog; 2017 Sep; 33(5):1235-1242. PubMed ID: 28842958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of Lactobacillus kefir cells for asymmetric synthesis of a 3,5-dihydroxycarboxylate.
    Pfruender H; Amidjojo M; Hang F; Weuster-Botz D
    Appl Microbiol Biotechnol; 2005 Jun; 67(5):619-22. PubMed ID: 15614560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural-guided design to improve the catalytic performance of aldo-keto reductase KdAKR.
    Dai C; Cao HX; Tian JX; Gao YC; Liu HT; Xu SY; Wang YJ; Zheng YG
    Biotechnol Bioeng; 2023 Dec; 120(12):3543-3556. PubMed ID: 37641876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the catalytic efficiency of aldo-keto reductase KmAKR towards t-butyl 6-cyano-(3R,5R)-dihydroxyhexanoate via semi-rational design.
    Yu H; Qiu S; Cheng F; Cheng YN; Wang YJ; Zheng YG
    Bioorg Chem; 2019 Sep; 90():103018. PubMed ID: 31220674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semi-rational engineering of a Kluyveromyces lactis aldo-keto reductase KlAKR for improved catalytic efficiency towards t-butyl 6-cyano-(3R, 5R)-dihydroxyhexanoate.
    Shen W; Chen Y; Qiu S; Wang DN; Wang YJ; Zheng YG
    Enzyme Microb Technol; 2020 Jan; 132():109413. PubMed ID: 31731953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semirational engineering of an aldo-keto reductase KmAKR for overcoming trade-offs between catalytic activity and thermostability.
    Li SF; Xie JY; Qiu S; Xu SY; Cheng F; Wang YJ; Zheng YG
    Biotechnol Bioeng; 2021 Nov; 118(11):4441-4452. PubMed ID: 34374988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer-aided design to enhance the stability of aldo-keto reductase KdAKR.
    Dai C; Tian JX; Chen YF; Ni YH; Cui L; Cao HX; Song LL; Xu SY; Wang YJ; Zheng YG
    Biotechnol J; 2024 Mar; 19(3):e2300637. PubMed ID: 38472092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved stereoselective bioreduction of t-butyl 6-cyano-(5R)-hydroxy-3-oxohexanoate by Rhodotorula glutinis through heat treatment.
    Luo X; Wang YJ; Zheng YG
    Biotechnol Appl Biochem; 2016 Nov; 63(6):795-804. PubMed ID: 26315716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of Kluyveromyces marxianus ZJB14056 aldo-keto reductase KmAKR to enhance diastereoselectivity and activity.
    Wang YJ; Ying BB; Shen W; Zheng RC; Zheng YG
    Enzyme Microb Technol; 2017 Dec; 107():32-40. PubMed ID: 28899484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient production of an ezetimibe intermediate using carbonyl reductase coupled with glucose dehydrogenase.
    Zhang XJ; Zhou R; Wu D; Tang YQ; Wang MY; Liu ZQ; Zheng YG
    Biotechnol Prog; 2021 Jan; 37(1):e3068. PubMed ID: 32822119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence-based screening for engineered aldo-keto reductase KmAKR with improved catalytic performance and extended substrate scope.
    Qiu S; Xu SY; Li SF; Meng KM; Cheng F; Wang YJ; Zheng YG
    Biotechnol J; 2021 Sep; 16(9):e2100130. PubMed ID: 34125995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.